TRIM33 and breast carcinoma: TRIM33 has been proposed as a prognostic predictor in breast cancer, where TRIM33 levels were reduced in both breast tissue and circulating plasma of breast cancer patients compared to healthy controls, and reduced TRIM33 expression was associated with worse overall survival [32].